These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 25816670)
1. [Associating of polymorphism in the promoter regions of genes of metalloproteinase (MMP2, MMP3, MMP9) with options of the clinical course of breast cancer in Russian women]. Shevchenko AV; Konenkov VI; Garbukov EIu; Stakheeva MN Vopr Onkol; 2014; 60(5):630-5. PubMed ID: 25816670 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
3. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298 [TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis]. Shevchenko AV; Konenkov VI; Korolev MA; Ubshaeva YB; Prokofiev VF Ter Arkh; 2015; 87(12):36-40. PubMed ID: 26978416 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955 [TBL] [Abstract][Full Text] [Related]
6. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710 [TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer. Zhang L; Xi RX; Zhang XZ Genet Mol Res; 2015 May; 14(2):4616-24. PubMed ID: 25966235 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population. Dey S; Stalin S; Gupta A; Saha D; Kesh K; Swarnakar S Mol Carcinog; 2012 Oct; 51 Suppl 1():E42-53. PubMed ID: 22121090 [TBL] [Abstract][Full Text] [Related]
13. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease]. Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638 [TBL] [Abstract][Full Text] [Related]
14. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302 [TBL] [Abstract][Full Text] [Related]
15. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740 [TBL] [Abstract][Full Text] [Related]
16. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. González-Arriaga P; Pascual T; García-Alvarez A; Fernández-Somoano A; López-Cima MF; Tardón A BMC Cancer; 2012 Mar; 12():121. PubMed ID: 22455335 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. Pöllänen PJ; Lehtimäki T; Mikkelsson J; Ilveskoski E; Kunnas T; Perola M; Penttilä A; Mattila KM; Nikkari ST; Syrjäkoski K; Karhunen PJ Atherosclerosis; 2005 May; 180(1):73-8. PubMed ID: 15823277 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Slattery ML; John E; Torres-Mejia G; Stern M; Lundgreen A; Hines L; Giuliano A; Baumgartner K; Herrick J; Wolff RK PLoS One; 2013; 8(5):e63165. PubMed ID: 23696797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]